By nominating 3D I am making no such suggestion. There is no contradiction by SI because I nominated that he nominated 3D, actually. It doesn't suit your narrative but that's for you to deal with.
I don't reckon they will struggle with label extensions from what I know of the likely extensions nominated so far. I'm sure of it.
The newly mentioned 'franchise' call is more SI p!ss and wind for mine. Throw it in there to make yourself feel better if you want - I guarantee it won't help you with your CYP investment.
SI is KK's peer. Get KK to persuade SI. Yet, that hasn't happened - not even close as far as I am aware. And it's the basis for your statements.
"development of ‘3D’ has been anaemic". What does that even mean?
I assume you are inferring it hasn't happened? Yeah, that's right. Horse before the cart. The last Mesoblast CR nominated funds to manufacturing - I assume that is 3D.
- Forums
- ASX - By Stock
- Ann: Publication comparing Cymerus MSCs to other MSCs
CYP
cynata therapeutics limited
Add to My Watchlist
6.25%
!
17.0¢

By nominating 3D I am making no such suggestion. There is no...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
17.0¢ |
Change
0.010(6.25%) |
Mkt cap ! $38.41M |
Open | High | Low | Value | Volume |
16.0¢ | 17.5¢ | 16.0¢ | $45.60K | 278.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 62994 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.5¢ | 107450 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 62994 | 0.160 |
4 | 66451 | 0.155 |
2 | 55000 | 0.150 |
2 | 45937 | 0.140 |
1 | 25000 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.175 | 107450 | 3 |
0.180 | 113494 | 5 |
0.185 | 35990 | 1 |
0.190 | 8868 | 1 |
0.195 | 22055 | 2 |
Last trade - 15.17pm 18/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online